Navigation Links
Silence Therapeutics' Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
Date:3/29/2011

LONDON, March 30, 2011 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") a leading global RNA interference (RNAi) therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology ("ASCO") Annual Meeting.  The meeting will take place in Chicago June 3-7, 2011.  Atu027, in clinical development for systemic cancer indications, is one of the most clinically advanced RNAi therapeutics in the area of oncology.  

Klaus Giese, Ph.D., chief scientific officer of Silence, and Dr. Dirk Strumberg, Professor of Medicine and Director, Department of Hematology and Medical Oncology, University of Bochum, Marienhospital Herne, the study's principal investigator, will present abstract #3057 titled "First-in-human phase I study of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3) in patients with advanced solid tumors."

The presentation will highlight data from Silence's ongoing, open label, single-centre, dose-finding Phase I study with Atu027 in subjects with advanced solid cancer.  Key findings presented will include safety, tolerability and pharmacokinetic data, as well as indications of antitumor activity.  Previously published preclinical data demonstrated that treatment with Atu027 prevented the spread of breast cancer to the lungs in preclinical models of cancer metastases, and interim data from the ongoing Phase I clinical trial suggests that Atu027 could have a similar therapeutic effect in humans.

"We are pleased to have our abstract accepted by ASCO and believe that presenting this data at such a prestigious scientific conference represents an important milestone in our efforts to translate our foundational RNAi technology into viable therapeutic products," said Philip Haworth
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
2. Silence Therapeutics Provides Year-end Update
3. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
4. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
5. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
6. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
7. Silence Therapeutics Announces Board Changes
8. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
9. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... Shakti, LLC, today announced that it has changed its name ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... our transformation into a company focused on patent claim analysis ... validity." In ... the Company commenced a corporate re-branding initiative in order to ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ... (NASDAQ: MYL ) shareholder vote regarding its planned ... of Mylan,s offer to Perrigo shareholders have always been, ... careful reflection of the value available to Perrigo shareholders, ... Mylan has allowed its shareholders to consider," said ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... BEDFORD, Ohio,  April 18, 2011 Bedford Laboratories™, ... pleased to announce the addition of Topotecan Hydrochloride ... portfolio.  Topotecan is AP Bioequivalent to the reference ... injection by GlaxoSmithKline. Topotecan Hydrochloride for Injection is ...
... April 18, 2011 Qmed.com, a UBM Canon ... informative video clips of products and services available ... Vault . Qmed is a free online search ... access to pre-qualified medical device suppliers. ...
Cached Medicine Technology:Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial 2Qmed Video Vault Showcases Innovative New Products and Services Available to Medical Device Manufacturers 2
(Date:8/28/2015)... ... 2015 , ... Medical Solutions, one of the nation’s largest travel nurse staffing ... by Modern Healthcare and will be honored at an awards dinner in Chicago ... Best Places to Work in Healthcare program recognizes outstanding employers in the healthcare industry ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
(Date:8/28/2015)... ... 28, 2015 , ... CARF International announced that West Ridge ... treatment and intensive family based services. , By pursuing and achieving accreditation, West ... of excellence. As a nonprofit charity for more than 50 years, West Ridge ...
(Date:8/28/2015)... ... , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with ... pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan ... then went on to earn his title of Doctor of Chiropractic from the Palmer ...
(Date:8/28/2015)... ... August 28, 2015 , ... SmartPractice Calendars afford ... with practice contact information and logos, Calendars stand alone as functional brand-building ... into seasonal mailings, thank you and welcome communications, and to complement statements and ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
... fossil teeth has thrown new light on the recent origin ... beings apart from their primate ancestors, according to an article ... of the fossil teeth, researchers from University College, London and ... 25 year development period of humans compared with 11 or ...
... Increasing folic acid intake and decreasing alcohol help beat the ... According to previous studies have shown that colon cancer often ... with the disease, you can opt for regular colon exams, ... and vegetables to reduce your cancer risk. ,According ...
... art is regnant among undergraduate university students, and there ... piercing,"// said Dr. Lester B. Mayers of the Pace ... lead author of the study. ,A survey ... had some type of body piercing and 22 percent ...
... ,According to researchers at the Hopkins Heart Institute, a blunt and ... When it comes to accidents and sports injuries,// it is a ... at the a blow to the chest may prove more hazardous. ... type of cardiac arrest called commotio cordis, which occurred after a ...
... dangerous parasitic disease from their new organs in the ... one recovered after antibiotic treatment.// A second study also ... turned up 26 bacterial infections traced to tissue grafts ... ,This shows that the graft-related infections show an ...
... prototype handheld detector under development at Sandia National Laboratories ... anthrax in less than five minutes. //Sandia's Laboratory Directed ... a multiprogram laboratory operated by Sandia Corporation, a Lockheed ... ,Fatty acids are found in all living organisms with ...
Cached Medicine News:
5mSports™ is the handheld version of 5 Minute Sports Medicine Consult, your favorite reference for on-field and off-field treatment of sports related problems....
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
... information that every intern needs from ... the neurologic history and physical examination, ... and diagnostic tools, and clinical information ... ataxia, acute vision loss, headache, movement ...
... an all-original guide prepared specifically ... Derived from "PocketMedicine/Internal Medicine", it ... to those training in the ... who are frequently the first ...
Medicine Products: